Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus.
Hutton DW, Prosser LA, Rose AM, Mercon K, Ortega-Sanchez IR, Leidner AJ, Havers FP, Prill MM, Whitaker M, Roper LE, Pike J, Britton A, Melgar M.
Hutton DW, et al. Among authors: leidner aj.
Vaccine. 2024 Oct 24;42(24):126294. doi: 10.1016/j.vaccine.2024.126294. Epub 2024 Sep 5.
Vaccine. 2024.
PMID: 39241353